| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 2.73e-11 | 5 | 156 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.63e-10 | 6 | 156 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.11e-07 | 16 | 156 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.78e-05 | 144 | 156 | 8 | GO:0016798 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.58e-04 | 103 | 156 | 6 | GO:0004553 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.04e-06 | 5 | 154 | 3 | GO:0045053 | |
| GeneOntologyCellularComponent | transcription export complex | 9.72e-05 | 12 | 163 | 3 | GO:0000346 | |
| Domain | Alpha_amylase | 4.93e-09 | 4 | 158 | 4 | IPR006046 | |
| Domain | Aamy_C | 4.93e-09 | 4 | 158 | 4 | SM00632 | |
| Domain | Alpha-amylase_C | 2.45e-08 | 5 | 158 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.45e-08 | 5 | 158 | 4 | IPR006048 | |
| Domain | Glyco_hydro_13_cat_dom | 1.69e-07 | 7 | 158 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 1.69e-07 | 7 | 158 | 4 | PF00128 | |
| Domain | Aamy | 1.69e-07 | 7 | 158 | 4 | SM00642 | |
| Domain | VPS13 | 5.94e-07 | 3 | 158 | 3 | IPR026847 | |
| Domain | VPS13_mid_rpt | 5.94e-07 | 3 | 158 | 3 | PF16910 | |
| Domain | VPS13 | 5.94e-07 | 3 | 158 | 3 | PF16908 | |
| Domain | A-amylase_C | 5.94e-07 | 3 | 158 | 3 | IPR031319 | |
| Domain | VPS13_N2 | 5.94e-07 | 3 | 158 | 3 | IPR031646 | |
| Domain | VPS13_mid_rpt | 5.94e-07 | 3 | 158 | 3 | IPR031642 | |
| Domain | SHR-BD | 2.36e-06 | 4 | 158 | 3 | IPR009543 | |
| Domain | VPS13_C | 2.36e-06 | 4 | 158 | 3 | PF16909 | |
| Domain | VPS13_C | 2.36e-06 | 4 | 158 | 3 | IPR031645 | |
| Domain | SHR-BD | 2.36e-06 | 4 | 158 | 3 | PF06650 | |
| Domain | CUB | 3.45e-06 | 49 | 158 | 6 | PF00431 | |
| Domain | CUB | 3.89e-06 | 50 | 158 | 6 | SM00042 | |
| Domain | - | 4.92e-06 | 52 | 158 | 6 | 2.60.120.290 | |
| Domain | CUB | 5.51e-06 | 53 | 158 | 6 | PS01180 | |
| Domain | Glyco_hydro_b | 6.26e-06 | 15 | 158 | 4 | IPR013780 | |
| Domain | CUB_dom | 8.47e-06 | 57 | 158 | 6 | IPR000859 | |
| Domain | Glyco_hydro_13 | 1.17e-05 | 6 | 158 | 3 | IPR015902 | |
| Domain | Chorein_N | 3.22e-05 | 8 | 158 | 3 | PF12624 | |
| Domain | VPS13_N | 3.22e-05 | 8 | 158 | 3 | IPR026854 | |
| Domain | Stonin | 7.11e-05 | 2 | 158 | 2 | IPR017110 | |
| Domain | Glycoside_hydrolase_SF | 8.41e-05 | 53 | 158 | 5 | IPR017853 | |
| Domain | DUF1220 | 9.32e-05 | 11 | 158 | 3 | PF06758 | |
| Domain | NBPF_dom | 9.32e-05 | 11 | 158 | 3 | IPR010630 | |
| Domain | NBPF | 9.32e-05 | 11 | 158 | 3 | PS51316 | |
| Domain | - | 2.02e-04 | 14 | 158 | 3 | 2.60.40.1180 | |
| Domain | SHD | 2.12e-04 | 3 | 158 | 2 | IPR012320 | |
| Domain | SHD | 2.12e-04 | 3 | 158 | 2 | PS51070 | |
| Domain | Glyco_hydro_catalytic_dom | 2.91e-04 | 38 | 158 | 4 | IPR013781 | |
| Domain | Autophagy-rel_C | 6.99e-04 | 5 | 158 | 2 | IPR015412 | |
| Domain | ATG_C | 6.99e-04 | 5 | 158 | 2 | PF09333 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 4.06e-09 | 9 | 115 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.47e-08 | 11 | 115 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 9.91e-07 | 23 | 115 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.80e-06 | 28 | 115 | 5 | M27837 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.87e-05 | 8 | 115 | 3 | MM14717 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.34e-05 | 52 | 115 | 5 | M14171 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.39e-11 | 6 | 166 | 5 | 2788608 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.39e-11 | 6 | 166 | 5 | 6608795 | |
| Pubmed | 1.39e-11 | 6 | 166 | 5 | 2081604 | ||
| Pubmed | 1.29e-10 | 8 | 166 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 5.01e-10 | 4 | 166 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 5.01e-10 | 4 | 166 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 5.01e-10 | 4 | 166 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 5.01e-10 | 4 | 166 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 5.01e-10 | 4 | 166 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 5.01e-10 | 4 | 166 | 4 | 94264 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 3872721 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 5.01e-10 | 4 | 166 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 5.01e-10 | 4 | 166 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 5.01e-10 | 4 | 166 | 4 | 2987507 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6091898 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 5.01e-10 | 4 | 166 | 4 | 6162108 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 16152770 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2423416 | ||
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 5.01e-10 | 4 | 166 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 5.01e-10 | 4 | 166 | 4 | 2989529 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 5.01e-10 | 4 | 166 | 4 | 1141004 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 5.01e-10 | 4 | 166 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 5.01e-10 | 4 | 166 | 4 | 6207174 | |
| Pubmed | 5.01e-10 | 4 | 166 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 5.01e-10 | 4 | 166 | 4 | 2332419 | |
| Pubmed | 5.52e-10 | 21 | 166 | 6 | 16079250 | ||
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 6529441 | ||
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 2.49e-09 | 5 | 166 | 4 | 34276419 | |
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 2.49e-09 | 5 | 166 | 4 | 8661735 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 2002257 | ||
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 7.45e-09 | 6 | 166 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 7.45e-09 | 6 | 166 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 7.45e-09 | 6 | 166 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 7.45e-09 | 6 | 166 | 4 | 7859283 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 7.45e-09 | 6 | 166 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.73e-08 | 7 | 166 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.73e-08 | 7 | 166 | 4 | 2451911 | |
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 7949740 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 6160178 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 8604219 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 8666240 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 2040456 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 3038891 | ||
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 3.45e-08 | 8 | 166 | 4 | 7523515 | |
| Pubmed | 3.45e-08 | 8 | 166 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 3.45e-08 | 8 | 166 | 4 | 6200103 | |
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 93520 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TOR1AIP2 ATRN NDST1 HSP90B1 FAT4 COL12A1 HACD3 BZW2 TMEM161B KIAA0319L ARFGEF1 SERPINH1 MYORG STT3A NRP1 BMP1 TENM3 PDIA5 C1QTNF6 SUCO CTSL DSE | 7.30e-08 | 1201 | 166 | 22 | 35696571 |
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 9121556 | ||
| Pubmed | 1.03e-07 | 10 | 166 | 4 | 2897103 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.07e-07 | 3 | 166 | 3 | 2413838 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.07e-07 | 3 | 166 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.07e-07 | 3 | 166 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.07e-07 | 3 | 166 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.07e-07 | 3 | 166 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.07e-07 | 3 | 166 | 3 | 17223109 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 15299664 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 8413315 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.07e-07 | 3 | 166 | 3 | 7678001 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 6098446 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 30982860 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 1699843 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 12527308 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 2414282 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 28659346 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 25588701 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 23449223 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 7608209 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 1617215 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 2903254 | ||
| Pubmed | 1.61e-07 | 11 | 166 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.61e-07 | 11 | 166 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.61e-07 | 11 | 166 | 4 | 8589528 | |
| Pubmed | 1.73e-07 | 27 | 166 | 5 | 8390965 | ||
| Pubmed | 2.40e-07 | 12 | 166 | 4 | 8144363 | ||
| Pubmed | Chromosomal localization of human Na+, K+-ATPase alpha- and beta-subunit genes. | 3.02e-07 | 30 | 166 | 5 | 2842249 | |
| Pubmed | 3.46e-07 | 13 | 166 | 4 | 489953 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 3.46e-07 | 13 | 166 | 4 | 7829080 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 2458567 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 20939500 | ||
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 15498460 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 4.26e-07 | 4 | 166 | 3 | 8543783 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 4.26e-07 | 4 | 166 | 3 | 16786601 | |
| Pubmed | 4.83e-07 | 14 | 166 | 4 | 2902233 | ||
| Pubmed | 4.83e-07 | 14 | 166 | 4 | 7894156 | ||
| Cytoband | 1p21 | 2.34e-08 | 24 | 166 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 4.59e-05 | 107 | 166 | 5 | chr1p21 | |
| Cytoband | 15q22.2 | 1.58e-04 | 29 | 166 | 3 | 15q22.2 | |
| Cytoband | 11q12-q13 | 1.93e-04 | 6 | 166 | 2 | 11q12-q13 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.16e-09 | 23 | 99 | 6 | 662 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | THOC1 TOR1AIP2 SMG1 HSP90B1 ZBTB2 HACD3 BZW2 ICE2 POLE2 AGPAT3 MYNN RFC1 CCNB1 KIF20A NLN CHCHD4 CCNE2 NBPF9 KICS2 PLPP4 SEMA6A METTL8 CDC25A CTSL | 8.46e-06 | 1407 | 165 | 24 | M14427 |
| Coexpression | LI_ESTROGENE_MCF7_E2_RESPONSE_UP | 1.73e-05 | 51 | 165 | 5 | M48219 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 2.19e-05 | 239 | 165 | 9 | MM1274 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 2.29e-05 | 54 | 165 | 5 | MM889 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 2.99e-05 | 57 | 165 | 5 | MM527 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | ARMT1 ZBTB2 COL12A1 BZW2 ARMC10 KIF20A NLN TIAM1 ATRNL1 NBPF9 SEMA6A C1QTNF6 RAB29 | 3.58e-05 | 534 | 165 | 13 | M12522 |
| Coexpression | BERGER_MBD2_TARGETS | 3.89e-05 | 11 | 165 | 3 | MM905 | |
| Coexpression | GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN | 4.12e-05 | 200 | 165 | 8 | M7347 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P4 | 4.15e-05 | 100 | 165 | 6 | M1734 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P4 | 5.76e-05 | 106 | 165 | 6 | MM1216 | |
| Coexpression | LE_EGR2_TARGETS_UP | 7.09e-05 | 110 | 165 | 6 | M12804 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.02e-06 | 141 | 166 | 7 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 163 | 166 | 7 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 163 | 166 | 7 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.70e-06 | 171 | 166 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 171 | 166 | 7 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.84e-06 | 172 | 166 | 7 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-06 | 173 | 166 | 7 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-06 | 175 | 166 | 7 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 175 | 166 | 7 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-06 | 180 | 166 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-06 | 180 | 166 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-06 | 182 | 166 | 7 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-06 | 182 | 166 | 7 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-06 | 184 | 166 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-06 | 184 | 166 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-06 | 184 | 166 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-06 | 186 | 166 | 7 | 4e983de6d2515082f9e555f4f949cec84281c140 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-06 | 190 | 166 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-06 | 190 | 166 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-06 | 190 | 166 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-06 | 191 | 166 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 192 | 166 | 7 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 192 | 166 | 7 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 7.90e-06 | 192 | 166 | 7 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.90e-06 | 192 | 166 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.18e-06 | 193 | 166 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-06 | 196 | 166 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-06 | 196 | 166 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.35e-06 | 197 | 166 | 7 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-06 | 197 | 166 | 7 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-06 | 198 | 166 | 7 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-06 | 198 | 166 | 7 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-05 | 200 | 166 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 200 | 166 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 154 | 166 | 6 | 1c62290a2558fd6401b27de5a867d243b143b00a | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.56e-05 | 155 | 166 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 161 | 166 | 6 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 161 | 166 | 6 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 161 | 166 | 6 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 161 | 166 | 6 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-05 | 164 | 166 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | lymphoid-B_cell-pro-B|lymphoid / Lineage, cell class and subclass | 3.63e-05 | 165 | 166 | 6 | 8126c2f7810fc6e09b18783aadf6434ae12b0514 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-05 | 166 | 166 | 6 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 166 | 166 | 6 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.88e-05 | 167 | 166 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 172 | 166 | 6 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 172 | 166 | 6 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-05 | 106 | 166 | 5 | ede8407ad253080d1fa2a6e2aacf549ce220309a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.04e-05 | 175 | 166 | 6 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 177 | 166 | 6 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 177 | 166 | 6 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-05 | 178 | 166 | 6 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-05 | 178 | 166 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 179 | 166 | 6 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 179 | 166 | 6 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 181 | 166 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 6.08e-05 | 181 | 166 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 181 | 166 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-05 | 182 | 166 | 6 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 6.86e-05 | 185 | 166 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 6.86e-05 | 185 | 166 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.06e-05 | 186 | 166 | 6 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.06e-05 | 186 | 166 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 186 | 166 | 6 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 186 | 166 | 6 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 187 | 166 | 6 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 187 | 166 | 6 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 187 | 166 | 6 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 187 | 166 | 6 | d72012e94857606f39975cf672f6b8c2e0fe093e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.49e-05 | 188 | 166 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.49e-05 | 188 | 166 | 6 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.72e-05 | 189 | 166 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-05 | 190 | 166 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-05 | 190 | 166 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 191 | 166 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 191 | 166 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 191 | 166 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-05 | 191 | 166 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-05 | 191 | 166 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 191 | 166 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-05 | 191 | 166 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-05 | 192 | 166 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-05 | 192 | 166 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-05 | 192 | 166 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-05 | 192 | 166 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.41e-05 | 192 | 166 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.41e-05 | 192 | 166 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-05 | 192 | 166 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-05 | 193 | 166 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-05 | 193 | 166 | 6 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-05 | 194 | 166 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 8.91e-05 | 194 | 166 | 6 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.91e-05 | 194 | 166 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-05 | 194 | 166 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-05 | 194 | 166 | 6 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.91e-05 | 194 | 166 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| Drug | 2-amino-6-picoline | 1.09e-10 | 6 | 164 | 5 | CID000015765 | |
| Drug | R 623 | 1.09e-10 | 6 | 164 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.09e-10 | 6 | 164 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 1.09e-10 | 6 | 164 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.09e-10 | 6 | 164 | 5 | CID000127364 | |
| Drug | CNP-G3 | 1.09e-10 | 6 | 164 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 3.79e-10 | 7 | 164 | 5 | CID000174858 | |
| Drug | Paramax | 3.79e-10 | 7 | 164 | 5 | CID000156411 | |
| Drug | BG5P | 3.79e-10 | 7 | 164 | 5 | CID003082752 | |
| Drug | desethylaprophen | 1.00e-09 | 8 | 164 | 5 | CID000163919 | |
| Drug | azintamide | 1.00e-09 | 8 | 164 | 5 | CID000071105 | |
| Drug | aprophen | 2.20e-09 | 18 | 164 | 6 | CID000071128 | |
| Drug | alpha-maltosyl fluoride | 2.25e-09 | 9 | 164 | 5 | CID000194237 | |
| Drug | trestatin A | 2.25e-09 | 9 | 164 | 5 | CID003054994 | |
| Drug | N-PMT | 2.60e-09 | 4 | 164 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 2.60e-09 | 4 | 164 | 4 | CID003482066 | |
| Drug | SAIB-SG | 2.60e-09 | 4 | 164 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 2.60e-09 | 4 | 164 | 4 | CID013573844 | |
| Drug | Dembrexine | 2.60e-09 | 4 | 164 | 4 | CID000072009 | |
| Drug | g lw | 2.60e-09 | 4 | 164 | 4 | CID000444139 | |
| Drug | beta-santalene | 2.60e-09 | 4 | 164 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 4.46e-09 | 10 | 164 | 5 | CID000485275 | |
| Drug | I ZE | 4.46e-09 | 10 | 164 | 5 | CID009549200 | |
| Drug | CG-120 | 4.46e-09 | 10 | 164 | 5 | CID000171403 | |
| Drug | Glc)4 | 4.46e-09 | 10 | 164 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 4.46e-09 | 10 | 164 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 4.46e-09 | 10 | 164 | 5 | CID000118008 | |
| Drug | validamycin D | 8.14e-09 | 11 | 164 | 5 | CID000166726 | |
| Drug | FG5P | 8.14e-09 | 11 | 164 | 5 | CID000127486 | |
| Drug | CNP-G5 | 8.14e-09 | 11 | 164 | 5 | CID000127309 | |
| Drug | HgI2 | 8.14e-09 | 11 | 164 | 5 | CID000024485 | |
| Drug | 2C KM | 8.14e-09 | 11 | 164 | 5 | CID009549196 | |
| Drug | Deposiston | 1.29e-08 | 5 | 164 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.29e-08 | 5 | 164 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.29e-08 | 5 | 164 | 4 | CID000161413 | |
| Drug | himachalene | 1.29e-08 | 5 | 164 | 4 | CID000015095 | |
| Drug | actinidine | 1.29e-08 | 5 | 164 | 4 | CID000068231 | |
| Drug | 2TAA | 1.29e-08 | 5 | 164 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.29e-08 | 5 | 164 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.29e-08 | 5 | 164 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.29e-08 | 5 | 164 | 4 | CID000155287 | |
| Drug | azaprophen | 1.39e-08 | 12 | 164 | 5 | CID000129486 | |
| Drug | CTK2H7378 | 1.39e-08 | 12 | 164 | 5 | CID005462310 | |
| Drug | methyl 1'-epiacarviosin | 2.24e-08 | 13 | 164 | 5 | CID000197426 | |
| Drug | isoacarbose | 2.24e-08 | 13 | 164 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 3.47e-08 | 14 | 164 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 3.47e-08 | 14 | 164 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 3.47e-08 | 14 | 164 | 5 | CID000007488 | |
| Drug | phenol blue | 3.85e-08 | 6 | 164 | 4 | CID000075078 | |
| Drug | Gu-4 | 3.85e-08 | 6 | 164 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 3.85e-08 | 6 | 164 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 3.85e-08 | 6 | 164 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 3.85e-08 | 6 | 164 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 3.85e-08 | 6 | 164 | 4 | CID006857368 | |
| Drug | vermella | 3.85e-08 | 6 | 164 | 4 | CID000203726 | |
| Drug | hymenin | 3.85e-08 | 6 | 164 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 3.85e-08 | 6 | 164 | 4 | CID000011615 | |
| Drug | 4-nitrophenylmaltoheptaoside | 5.17e-08 | 15 | 164 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 7.47e-08 | 16 | 164 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 7.47e-08 | 16 | 164 | 5 | CID003085308 | |
| Drug | methyl blue | 8.93e-08 | 7 | 164 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 8.93e-08 | 7 | 164 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 8.93e-08 | 7 | 164 | 4 | CID000071762 | |
| Drug | amino-methyl | 8.93e-08 | 7 | 164 | 4 | CID000142005 | |
| Drug | Folin Marenzi reagent | 9.89e-08 | 32 | 164 | 6 | CID000452313 | |
| Drug | trimitan | 1.45e-07 | 18 | 164 | 5 | CID000005561 | |
| Drug | boric acid gel | 1.78e-07 | 8 | 164 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.78e-07 | 8 | 164 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 1.78e-07 | 8 | 164 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.78e-07 | 8 | 164 | 4 | CID000146692 | |
| Drug | acrinor | 1.78e-07 | 8 | 164 | 4 | CID005489637 | |
| Drug | NSC300622 | 1.78e-07 | 8 | 164 | 4 | CID000028426 | |
| Drug | theodrenaline | 1.78e-07 | 8 | 164 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.78e-07 | 8 | 164 | 4 | CID000073372 | |
| Drug | Lugol's iodine | 1.95e-07 | 19 | 164 | 5 | CID000105053 | |
| Drug | BCDs | 2.46e-07 | 37 | 164 | 6 | CID000364214 | |
| Drug | GSAD | 3.18e-07 | 9 | 164 | 4 | CID009909127 | |
| Drug | GU-3 | 3.18e-07 | 9 | 164 | 4 | CID000448687 | |
| Drug | zingiberene | 3.18e-07 | 9 | 164 | 4 | CID000092776 | |
| Drug | Atonik | 3.18e-07 | 9 | 164 | 4 | CID000069471 | |
| Drug | H 187 | 3.18e-07 | 9 | 164 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 3.18e-07 | 9 | 164 | 4 | CID000024864 | |
| Drug | AC1L3XPY | 3.38e-07 | 21 | 164 | 5 | CID000124005 | |
| Drug | AC1N3UXZ | 3.67e-07 | 3 | 164 | 3 | CID004118625 | |
| Drug | maltoheptose | 3.99e-07 | 40 | 164 | 6 | CID003037125 | |
| Drug | Eudragit RS | 4.35e-07 | 22 | 164 | 5 | CID000104931 | |
| Drug | maltosaccharide | 4.35e-07 | 22 | 164 | 5 | CID005461034 | |
| Drug | trans-cinnamamide | 5.27e-07 | 10 | 164 | 4 | CID000012135 | |
| Drug | eicosa-11,14-dienoic acid | 5.27e-07 | 10 | 164 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 5.27e-07 | 10 | 164 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 5.27e-07 | 10 | 164 | 4 | CID000440202 | |
| Drug | taselin | 5.53e-07 | 23 | 164 | 5 | CID000023846 | |
| Drug | Panose B | 6.94e-07 | 24 | 164 | 5 | CID000439297 | |
| Drug | Tempamine | 8.23e-07 | 11 | 164 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 8.23e-07 | 11 | 164 | 4 | CID000164608 | |
| Drug | AMO-1618 | 8.23e-07 | 11 | 164 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 8.23e-07 | 11 | 164 | 4 | CID000430710 | |
| Drug | CID439354 | 8.62e-07 | 25 | 164 | 5 | CID000439354 | |
| Drug | chloroisocyanuric acid | 1.23e-06 | 12 | 164 | 4 | CID000017921 | |
| Drug | glyciphosphoramide | 1.23e-06 | 12 | 164 | 4 | CID000197092 | |
| Disease | alpha-amylase 1 measurement | 9.28e-08 | 9 | 156 | 4 | EFO_0801371 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.45e-07 | 3 | 156 | 3 | DOID:0111611 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 7.96e-06 | 8 | 156 | 3 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 2.78e-05 | 2 | 156 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 2.78e-05 | 2 | 156 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 9.98e-05 | 139 | 156 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 9.98e-05 | 139 | 156 | 6 | C0025363 | |
| Disease | Mental deficiency | 9.98e-05 | 139 | 156 | 6 | C0917816 | |
| Disease | ADP-ribosylation factor-like protein 11 measurement | 1.65e-04 | 4 | 156 | 2 | EFO_0801355 | |
| Disease | potassium voltage-gated channel subfamily A member 10 measurement | 2.75e-04 | 5 | 156 | 2 | EFO_0802888 | |
| Disease | whole-brain volume | 2.75e-04 | 5 | 156 | 2 | EFO_0005089 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 4.11e-04 | 6 | 156 | 2 | C1834523 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 5.73e-04 | 7 | 156 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | diabetic retinopathy | 7.99e-04 | 136 | 156 | 5 | EFO_0003770 | |
| Disease | Distal arthrogryposis | 9.76e-04 | 9 | 156 | 2 | cv:C0265213 | |
| Disease | axin-2 measurement | 1.22e-03 | 10 | 156 | 2 | EFO_0801400 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 1.48e-03 | 11 | 156 | 2 | C0268362 | |
| Disease | cytochrome p450 3a4 measurement | 1.48e-03 | 11 | 156 | 2 | EFO_0020303 | |
| Disease | Parkinson disease | 1.65e-03 | 321 | 156 | 7 | MONDO_0005180 | |
| Disease | phenylacetate measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0021012 | |
| Disease | integral membrane protein 2B measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0802634 | |
| Disease | Granulomatosis with Polyangiitis | 2.08e-03 | 13 | 156 | 2 | EFO_0005297 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.08e-03 | 13 | 156 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | depressive symptom measurement, stressful life event measurement | 2.37e-03 | 50 | 156 | 3 | EFO_0007006, EFO_0007781 | |
| Disease | Malformations of Cortical Development | 2.42e-03 | 14 | 156 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.42e-03 | 14 | 156 | 2 | C0431380 | |
| Disease | myocardial infarction | 2.68e-03 | 350 | 156 | 7 | EFO_0000612 | |
| Disease | Tinnitus, response to cisplatin | 2.79e-03 | 15 | 156 | 2 | GO_0072718, HP_0000360 | |
| Disease | Hypertriglyceridemia | 2.79e-03 | 15 | 156 | 2 | C0020557 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 2.79e-03 | 15 | 156 | 2 | DOID:655 (is_implicated_in) | |
| Disease | Pontoneocerebellar hypoplasia | 3.17e-03 | 16 | 156 | 2 | cv:C1261175 | |
| Disease | cathepsin L1 measurement | 3.17e-03 | 16 | 156 | 2 | EFO_0010619 | |
| Disease | response to lithium ion | 3.27e-03 | 56 | 156 | 3 | GO_0010226 | |
| Disease | C-C motif chemokine 3 measurement | 4.02e-03 | 18 | 156 | 2 | EFO_0008051 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 4.48e-03 | 19 | 156 | 2 | EFO_0802076 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSELATEVHFYGKTI | 271 | Q9H993 | |
| SHIEGDIFSSFKAGY | 86 | Q01362 | |
| SVDHFAKYFTDAGLK | 226 | Q9Y6E2 | |
| FQTGTSSLHVYDGKF | 146 | P06276 | |
| FYSDISVSAAGFHLE | 1886 | Q7Z408 | |
| AAVYALDHFSKSLFL | 361 | O15254 | |
| HYLSGFIKKTSDAES | 1411 | Q8N7X0 | |
| TAAHFGLSELVAFYV | 181 | Q9Y574 | |
| KGSYVSIHSSGFRDF | 36 | Q13838 | |
| FTVSTDKAQRHFGYE | 331 | Q9H2F3 | |
| FLYILETSTSSFDHK | 531 | Q9Y6D6 | |
| TTQGFLDFETKQSYH | 3251 | Q6V0I7 | |
| HKEIGTSDFSRFTNY | 76 | O96020 | |
| KIYVSDDGKAHFSIS | 481 | P0DTE7 | |
| KIYVSDDGKAHFSIS | 481 | P0DTE8 | |
| HAVFLYTSQALFEKD | 3766 | Q96DT5 | |
| LDLSKAQFHSGLYTE | 206 | P56282 | |
| GDETYFSFLRKFVHT | 601 | Q8N6M6 | |
| KIYVSDDGKAHFSIS | 481 | P0DUB6 | |
| LSTYFGKEAEVVAHT | 236 | Q6P656 | |
| KIYVSDDGKAHFSIS | 481 | P19961 | |
| EVYSAGDSVLVKFHS | 946 | P13497 | |
| FTSLGYEVQKFLHLS | 271 | O15519 | |
| DSSFLSLYDSHVAKE | 261 | Q8N2F6 | |
| KDHIFSSYTAFGDLE | 266 | Q8WWH4 | |
| FSRKHIFYEIGSNSG | 491 | A8MX76 | |
| FYTKNGHSLGIAFTD | 181 | Q6VN20 | |
| HTTDASLRKYFEVFG | 21 | Q9BX46 | |
| HIDIIGSSSDTYLFK | 331 | Q6ZSC3 | |
| SFSKHYKSTVGVDFA | 31 | O14966 | |
| HERAKELYSSGEFSS | 336 | Q96HW7 | |
| FLFSIETETTIGYGH | 111 | Q92806 | |
| EITYSFFGVADKAQH | 276 | Q9Y5F8 | |
| KIYVSDDGKAHFSIS | 481 | P04746 | |
| IAHRFGFVQDKYSAS | 1476 | O75140 | |
| SEHYGSETLREFLKF | 201 | Q9C0D6 | |
| LHYTKLAEKSSGFET | 1396 | Q8WXI7 | |
| HFVSILSFSELGYTA | 61 | Q8NGY5 | |
| FLEGLRYTAKHSSLF | 26 | Q8NGN2 | |
| NHSFALTLFGYGKTE | 361 | Q96RG2 | |
| EKLLFYCDSQGFHSV | 41 | O43300 | |
| HAEEGRASIYKSVFS | 46 | P31513 | |
| ADFHFSSTLGIQEKY | 281 | Q9H9Y4 | |
| KTLSVYEKHSFFGGD | 351 | Q8NG48 | |
| FTSSGSRKLYFDTHA | 156 | Q96AQ8 | |
| ELYKTFQHGLDESAS | 746 | Q8IV33 | |
| SEFHLTVLAYNSKGA | 886 | O00533 | |
| RFCILGKESFYDTFH | 171 | Q9P035 | |
| SSVHQDFLGFYVLDS | 806 | P19827 | |
| FLSNLVEGTYTFHLK | 751 | Q8IZA0 | |
| AFSCFHYSTEEIKGS | 71 | Q8N4Q1 | |
| ALLHFFSDAAYNLTG | 226 | O75882 | |
| AFKGLHSYFITVTEE | 251 | Q9P2D6 | |
| DTNLAEAGHFFYKSK | 2996 | Q9Y6V0 | |
| TFAVSHLGSKYNSLD | 3996 | Q9Y6V0 | |
| SLHDELGKFSSTLYE | 871 | Q96RV3 | |
| KSQEHFTALGSFYFL | 96 | Q14642 | |
| FTALGSFYFLHESLK | 101 | Q14642 | |
| SYFGTENLKSLVLHF | 376 | Q9UBU9 | |
| SADVLHATAYFLSKE | 561 | O60658 | |
| SIHVYGKTEDFISQF | 1011 | Q96J66 | |
| KAHRNVLASFSEYFG | 36 | Q9NPC7 | |
| LKYTFHEVITAGSDA | 726 | P52848 | |
| LAHSLVGFATAYDFL | 151 | Q9UL01 | |
| HFVLGTSAYFESLVE | 701 | P16885 | |
| STSHEQGKFIALFYT | 266 | Q8N628 | |
| NVKFFYLVSLSHDSG | 471 | Q6IE36 | |
| VSELTAYFFSHKLIE | 491 | Q6ZSS7 | |
| LAEGFYTTSAVKELH | 106 | Q13491 | |
| FTTFYLAGKLHCFTE | 156 | Q5VZY2 | |
| EFKFHSLSSNLYEEV | 296 | Q96LP2 | |
| HVLSKEFTSYFSSGA | 66 | Q96M15 | |
| HTLAYVSDLGKVFSF | 306 | Q9UII4 | |
| FFSHLGIFSYDKAKD | 21 | Q96MD2 | |
| IKFVSDYETHGAGFS | 121 | O14786 | |
| GLDATTFSKLHSLEY | 256 | Q6PEZ8 | |
| LKHASTVAGGFFSLY | 51 | Q9H237 | |
| LVTYAASALLHGFSF | 331 | Q9H237 | |
| AYIHFTAEGEVTFKS | 371 | P14625 | |
| FHSTETIVDGKLYDA | 371 | Q9HB29 | |
| LTFHFYSDSSISGKG | 1941 | O60494 | |
| LNEFVSHYTKTSDGL | 186 | P42685 | |
| SKTSFDDEHGFYLKV | 81 | Q9NR20 | |
| NTFTLSYDGSLRHKF | 1416 | P04114 | |
| EPLAFTFSHDYKGST | 1936 | P04114 | |
| VALKDFHSEYIVSAS | 4416 | P04114 | |
| IGDFAFVTDNTYTKH | 266 | P14635 | |
| GLKTFFSRENYKDHS | 21 | Q659A1 | |
| FYVGHIDAFTSKLFL | 806 | Q659A1 | |
| GAFYTAETSENAKLH | 1476 | Q86XA9 | |
| DFDTYITFSGHLIKA | 261 | Q9BXI9 | |
| DTEEVKTLFYGSFHK | 2636 | Q99715 | |
| TLSYTFFEAKEGHKL | 256 | Q9Y6N1 | |
| HFGTREKFSDASYQS | 511 | P01031 | |
| VTTSGYALLHFFSDA | 181 | Q5VV63 | |
| SKSDALETLGFLNHY | 551 | P14866 | |
| YFTSNGLVTKALEHA | 2426 | Q14204 | |
| TFSYTLEDHTKQAFG | 51 | Q14145 | |
| SFKYGDILHVINASD | 561 | Q15700 | |
| HYSNTLKALGISDEF | 571 | Q3B820 | |
| SFKSGRADLAAIYHE | 176 | Q6UWR7 | |
| LDHTDDDFYSKFSTG | 491 | P34947 | |
| KFYTDAAFLLSDAHV | 151 | Q92622 | |
| DAGLEKIHLSFYLTS | 206 | Q9NQL2 | |
| FASGAVELVKSHSSY | 231 | Q9H825 | |
| DLIGDFSKGYLFHTV | 336 | P30304 | |
| GAFHTEYNRAVTFKS | 116 | Q14554 | |
| FVLTKASLAYFEDRH | 31 | Q08881 | |
| VTFLSGKKYSVDDLH | 461 | Q14995 | |
| ITTKFGDSFYFLSNH | 196 | Q9NP80 | |
| DYISVFDVKSGSAVH | 166 | Q969X6 | |
| SFDVLLSHKYGVAAF | 56 | P57771 | |
| HFESFPAGSTLIFYK | 366 | Q8NFQ8 | |
| DHGDISFYSFRDFTL | 506 | Q7Z6J9 | |
| VLFSLTTHYFKVEDG | 151 | Q8NDZ6 | |
| GSSFYALEEKHVGFS | 976 | P0DPF3 | |
| SSFYALEEKHVGFSL | 1296 | Q6P3W6 | |
| GSSFYALEEKHVGFS | 2271 | Q6P3W6 | |
| SSFYALEEKHVGFSL | 2516 | Q6P3W6 | |
| GSSFYALEEKHVGFS | 3491 | Q6P3W6 | |
| GSSFYALEEKHVGFS | 786 | Q5TI25 | |
| GSSFYALEEKHVGFS | 536 | Q8N660 | |
| GSSFYALEEKHVGFS | 536 | A0A087WUL8 | |
| SSFYALEEKHVGFSL | 781 | A0A087WUL8 | |
| GSSFYALEEKHVGFS | 1756 | A0A087WUL8 | |
| SSFYALEEKHVGFSL | 2001 | A0A087WUL8 | |
| GSSFYALEEKHVGFS | 2976 | A0A087WUL8 | |
| SSFYALEEKHVGFSL | 3221 | A0A087WUL8 | |
| GSSFYALEEKHVGFS | 436 | P0DPF2 | |
| SSFYALEEKHVGFSL | 681 | P0DPF2 | |
| GSSFYALEEKHVGFS | 1656 | P0DPF2 | |
| SSFYALEEKHVGFSL | 1901 | P0DPF2 | |
| GSSFYALEEKHVGFS | 2876 | P0DPF2 | |
| SSFYALEEKHVGFSL | 3121 | P0DPF2 | |
| GSSFYALEEKHVGFS | 4096 | P0DPF2 | |
| SSFYALEEKHVGFSL | 4341 | P0DPF2 | |
| SLVDKSDLFFHDYSI | 866 | P35251 | |
| DFTYSKDDFHRAGLQ | 331 | P55055 | |
| GLHFSFQTADKLYFV | 161 | O00141 | |
| DFSDVISFILYGNSH | 861 | Q96Q15 | |
| ASFYGHSEFELAIAL | 236 | Q9H479 | |
| SLSYHSGQKFSTFDR | 176 | P55083 | |
| SGKKDLYLASVFHAT | 341 | P50454 | |
| TTRFLAEEGFYKFHN | 56 | P46977 | |
| DSGFAKTSVAASLYH | 2496 | Q7Z333 | |
| FAVSASLASIHADKY | 291 | Q8NG04 | |
| AGLSFFTYETLKSLH | 201 | Q86VD7 | |
| ISYIDDFAKEGHSSL | 146 | G3V0H7 | |
| VLQGKHSTYDTDLFS | 276 | Q5JTZ9 | |
| GTTNYDDFLSFIHAV | 531 | Q8WXE9 | |
| DFDYSGTSLKALSIH | 291 | Q15399 | |
| SVAIDAGHESFLFYK | 246 | P07711 | |
| KLKGSHSSFDEAYFR | 106 | Q8N957 | |
| SGVKFKEFIHYLLDS | 326 | Q7L1S5 | |
| LRKLIFTSVYFGHDS | 661 | Q7RTR0 | |
| AKLLGYSTHADFVLE | 291 | Q9BYT8 | |
| LADYKGVSLSKASHF | 186 | Q9BTX7 | |
| IFHKVLSSGCDYSEL | 166 | P46094 | |
| LDSLPSKYHVTFFGE | 351 | Q9H0M4 | |
| VITFLDYHDGAATFL | 2401 | Q96RL7 | |
| FLLYCEGTRFTETKH | 171 | Q9NRZ7 | |
| IHIEKSDTAADTYGF | 846 | Q13009 | |
| LKLGSTSYHDFLDFL | 376 | Q9Y6Q2 | |
| FAPFHGYSKSEDLSS | 976 | Q96PV0 | |
| IAHSVFSKGDSAYLS | 476 | Q6PCB7 | |
| YDETLHVAKFSAIAS | 491 | O95235 | |
| FAAYGSAVLTFDLHA | 266 | A6NE52 | |
| LFADGKLYSATVTDF | 176 | Q9H2E6 | |
| SIFLDHISSLDYFTK | 256 | Q6IQ55 | |
| YSKAVSFEHLSFGSQ | 1831 | Q9H5I5 | |
| KASFSHDFTYLVSGS | 791 | Q5JSH3 | |
| EVTFDFYHKASRLGS | 936 | Q8IWV7 | |
| SDFYDGFHIQSISAI | 511 | Q9BY07 | |
| TLKAFDHDSSRLLYG | 46 | Q9P273 | |
| DKLFTAIGYSESTHN | 506 | Q709C8 | |
| FSTIYKHFDENLTGR | 2276 | P02549 | |
| TFFIARGNKAEHYTA | 141 | Q147U7 | |
| YIKVELLSHFGSEHF | 426 | Q9UBS9 | |
| STLKHEGFYSENLTE | 111 | Q96AP4 | |
| GDVYFKAHKSVLASF | 31 | Q8N680 | |
| KDDLSFAGYQKHLSS | 126 | Q6IBS0 | |
| STFRHDLKIYASDEG | 566 | Q6PFW1 | |
| LFHYSALLSAFGEAN | 121 | Q8IZJ6 | |
| TGGEHVYFAKFLTSE | 291 | Q96FV9 | |
| HFLREEYGTFSLAKS | 261 | Q9NX78 | |
| YGFDLASSHLDTVKL | 1361 | Q5THJ4 | |
| GFTGYISSSLHKFEL | 441 | Q8IZF0 | |
| SVASFKFDAGEVSYL | 456 | Q6NSJ0 |